Home Overview Press Room Blog Publications For Students about us
Search

Sequencing & Genomics : Displaying 333-342 of 1335


Myriad Genetics Ending Patent Dispute on Breast Cancer Risk Testingby Andrew PollackThe New York TimesJanuary 27th, 2015The company has settled or is in the process of settling patent-infringement lawsuits it filed against other companies that now offer such testing.
Genetic Testing and Tribal Identityby Rose EvelethThe AtlanticJanuary 26th, 2015The question of genetic testing, and particularly genetic testing to determine ancestral origins, is controversial for many Native Americans.
Privacy is dead, Harvard professors tell Davos forumAgence France PresseJanuary 22nd, 2015"We are at the dawn of the age of genetic McCarthyism," said one Harvard researcher.
US Precision-Medicine Proposal Sparks Questionsby Sara ReardonNatureJanuary 22nd, 2015President Obama announced a "Precision Medicine Initiative" in his State of the Union address, but the White House is remaining tight-lipped about the details.
UK Moratorium on Use of Genetic Tests by Insurers Extendedby Philippa BricePHG FoundationJanuary 21st, 2015The purpose of the UK moratorium is similarly to ensure that individuals are not debarred from health or life insurance as a result of genetic testing.
After Canada, UK, 23andMe Wants DNA Test Growth Abroadby Caroline Humer and Christina FarrReutersJanuary 15th, 2015The company, whose consumer-directed tests were barred by U.S. health regulators in 2013, said Western Europe is one focus for expansion.
Direct-to-Consumer Genetic Tests Should Come With a Health Warningby Jessica CussinsThe Pharmaceutical JournalJanuary 15th, 2015Genetic testing is appropriate in certain situations, but for healthy people as a way to predict disease, it is imprecise and comes with a number of risks.
Deals For Genetic Data Raise Issues of Privacy, Sharingby John Lauerman and Makiko KitamuraBloombergJanuary 14th, 2015Big Pharma is making deals to use the personal genetic data accumulated by direct-to-consumer genetic testing companies and others.
23andMe Turns Spit Into Dollars in Deal With Pfizerby Caroline ChenBloombergJanuary 12th, 2015The genetic-testing company backed by Google is sharing DNA data on about 650,000 individuals with Pfizer, the U.S.ís largest drugmaker.
23andMeís New Formula: Patient Consent = $by Antonio RegaladoMIT Technology ReviewJanuary 6th, 2015How a consumer genetics company amassed a lucrative database of willing research participants.
Displaying 333-342 of 1335  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1122 University Ave, Suite 100, Berkeley, CA 94702 • • (p) 1.510.665.7760 • (F) 1.510.665.8760